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Summary: The aim of this study was the elucidation of the role of the xanthine oxidoreductase in the purine
metabolism in ischaemic diseases of man. The serum concentrations of hypoxanthine, xanthine, uric acid and
allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and
myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy
males and females. No significant differences were observed for the serum hypoxanthine concentrations, xanthine
concentrations, the sum (hypoxanthine + xanthine) and the ratio (xanthine/hypoxanthine) between the healthy
males, healthy females, the patients suffering from angina pectoris and the patients suffering from cerebral insult.
An increase of the serum xanthine concentration in patients with myocardial infarction indicates a significant
metabolic involvement of xanthine oxidoreductase in this disease and therefore a possible role in the development
of tissue damage in the postischaemic phase due to oxygen radicals generated by the oxidase activity of this enzyme.
The serum concentrations of uric acid and allantoin showed no differences between any of the studied groups.
Study of the non-enzymatic oxidation of uric acid to allantoin by oxygen radicals, a relevant radical-scavenging
mechanism in other diseases, provided no indication of an increased concentration of oxygen radicals due to the
xanthine oxidoreductase reaction or other radical-producing mechanisms.
Introduction xanthine, xanthine, uric acid and allantoin in samples
from n = 115 patients with acute myocardial infarction
Xanthine oxidoreductase (EC 1.2.3.2) is the terminal en- were compared with those in samples from n = 180
zyme of purine metabolism. Physiologically this enzyme hea,thy ma,eS5 n = M5 hea]thy females> n = 45 patients
used NAD+ äs electron acceptor, but in ischaemia it with angina pectoris and n = 19 patients suffering from
may be converted from the dehydrogehase form to an cerebra] infarction. Furthermore the results of the serial
oxidase form, which uses molecular oxygen äs an determinations of the serum concentrations of hypoxan-
electron acceptor (1). Several studies have been per- t^n^ xanthine, the sum (hypoxanthine + xanthine) and
formed on the relevance of xanthine oxidase in tissue the ratio (xanthine/hypoxanthine) for n = 53 patients
destruction by oxygen-derived radicals. De Scheerder wjth clinically diagnosed acute myocardial infarction
concluded from the parallel coronary release of malon- were compared with classical clinical chemical markers
dialdehyde and uric acid, that there is an enhanced un- for the diagnosis and follow-up of this disease. The
specific oxidation of membrane phospholipids by oxy- method used for the simultaneous determination of hy-
gen-derived radicals produced by xanthine oxidase (2). poxanthine, xanthine, uric acid and allantoin from serum
In the present study the serum concentrations of hypo- was presented in a previous publication (3).
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Fig. l a-b Distribution of serum hypoxanthine concentrations
and serum xanthine concentrations for the reference groups (heaK







































Munichi Germany) were used. rie acid was Standard Reference
Material with a.purity of 99.7% (SRM 913, National Bureau of
Standards, Washington D. C. 20234). The reagents required f r the
For the preparation of Standard Solutions of allantoin, hyppxanthine" determinatioii of the enzyme acti vities of creatine kinase and cre-
and xanthine, materials of the highest available purity (SIGMA, atine kinase isoenzyme MB wejrp from Boehringer Mannheim.
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All other Chemicals were purchased from Merck (Darmstadt,
Germany) and were of analytical grade; methanol was of
HPLC-grade.
Samples
For the drawing blood the Sarstedt-system with separation-gel was
used and the time between blood withdrawal and centrifugation
never exceeded 30 min.
The samples in this study were from 180 healthy adult males, 145
healthy adult females, 155 adult patients with acute myocardial
infarction and successful thrombolytic therapy according to clinical
observations, 45 patients suffering from angina pectoris, and 19
patients with a cerebral infarction. The patient samples were drawn
within 3-7 h after hospitalization.
All the samples taken from 53 patients with acute myocardial in-
farction for diagnostic purposes and follow-up were analysed.
These patients showed early reperfusion of the occluded coronary
artery spontaneously or s a result of therapeutic lysis.
High performance liquid chromatography
HPLC was performed on a Waters chromatography System with a
gradient pump Model 600, a Satellite WISP Model 700 and a tune-
able wavelength detector Model 481. System control, data acquisi-
tion, Integration and calibration were performed with the Waters
Maxima 825 Software. Chromatographie separations were per-
formed s described in 1. c. (3). For the determination of hypoxan-
thine, xanthine and uric acid, UV-detection was performed at 254
nm with a r nge of 0.005 absorbance units f ll scale and a time
constant of l .0 s. For the determination of allantoin s described
in 1. c. (3), UV-detection was performed at 360 nm with a r nge of
0.100 absorbance units f ll scale and a time constant of 1.0 s.
The method used in this study had a detection limit for hypoxan-
thine of l pmol and for xanthine of l .5 pmol; since 50 μΐ of five-
fold diluted serum were injected, the lower concentration limit for
hypoxanthine and xanthine was 0.1 μηηοΐ/ΐ and 0.15 μπιοΐ/ΐ, respec-
tively. For serum hypoxanthine concentrations of 5-50 μιτιοΐ/ΐ the
coefficient of Variation did not exceed 5%; for xanthine concentra-
tions of 2-20 μιτιοΐ/ΐ the imprecision was less than 7%.
Determination of enzyme act ivi t ies
The determination of the enzyme activities of creatine kinase and
creatine kinase-MB were performed on a Hitachi 747 at 25 °C with
the reagent kits obtained from Boehringer Mannheim.
Statistical procedures and ca l cu l a t ions
For data management, Microsoft Excel 3.0a (Microsoft GmbH,
Munich, Germany) was used. Statistical treatments, including the
calculation of the Bayesian parameters for the sample classifica-
tion, were performed with the Statistical package Sigmastat V 1.02
(Jandel Scientific GmbH, Erkrath, Germany).
Results
Hypoxanthine and xanthine from single serum
samples
In figure l a—b the distribution of the hypoxanthine and
xanthine concentrations in sera from patients with myo-
Tab. l Results for the determination of hypoxanthine, xanthine,
the sum (hypoxanthine + xanthine) and the ratio (xanthine/hypo-
xanthine). The samples from the patients were drawn at the inten-
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cardial infarction are shown versus those obtained for
healthy males, healthy females, patients with angina
pectoris and patients with cerebral insult. Table l shows
the statistical quantities of the distributions, and the sta-
tistical quantities of the distribution of the sum (hypo-
xanthine + xanthine), the ratio (xanthine/hypoxanthine),
total creatine kinase activity and creatine kinase-MB ac-
tivity. 7he data of the n = 45 patients suffering from
angina pectoris and of the n = 19 patients suffering from
cerebral insult cannot be discriminated from the data ob-
tained for healthy males and healthy females. Sensitivity
and specificity of the studied analytes were calculated
from the results obtained for the samples from n = 155
patients suffering from myocardial infarction and the re-
sults for the n = 389 samples combined from the four
groups of healthy males, healthy females, angina pecto-
ris and cerebral insult. Hypoxanthine showed a sensitiv-
ity of 0.59 for a specificity of 0.90 at a discriminator
value of 14.7 μπιοΐ/ΐ, xanthine a sensitivity of 0.83 for
a specificity of 0.90 at a discriminator value of 4.5
μηηο1/1, the sum (hypoxanthine + xanthine) a sensitivity
of 0.77 for a specificity of 0.90 at a discriminator value
of 19.7 μιτιοΐ/ΐ, and the ratio (xanthine/hypoxanthine) a
sensitivity of 0.35 for a specificity of 0.90 at a discrimi-
nator value of 0.78. The ROC-curves are shown in fig-
ure 2.
Tab. 2 Results for the determination of uric acid and allantoin.
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Fig. 2 ROC-curves for serum hypoxanthine concentrations, se^·
rum xanthine concentrations, sum (hypoxanthine 4- xarithihe) and
ratio (xanthine/hypoxanthine) for the discrimination between a ref-
erence collective consisting of the normals, the patients with angina
pectoris and the patients with cerebral insult, and the patients with
myocardial infarction. The data used for the calculation are those
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Uric acid and allantoin from single serum
samples
Table 2 summarizes the data for the determination of
uric acid and allantoin from the samples used for the
data in figure l a—b. The distribution of the serum con-
centrations of uric acid and the distribution of serum
concentrations of allantoin in the samples from patients
with myocardial infarction was not significantly dif-
ferent from the distribution in the samples of the refer-
ence c llectives.
Release profiles of purines and total creatine
kinase/kreatine kinase-MB derived from sera
of patients with myocardial infarction
Figure 3a—b shows the data for hypoxanthine, xanthine,
total creatine kinase and creatine kinase-MB from serial
serum samples, obtained from n = 53 patients with
myocardial infarction, hospitalized at the cardiological
intensive care unit between 5 h and 150 h after pain on-
set. For the samples drawn initially (= 5 ± 2 h after pain
onset), only the median for the serum xanthine coneen-
tration exceeded the discriminator value for a specificity
of 0.90. For hypoxanthine in median of the meas fed
serum concentration feil below the discriminator value
for a speeificity of 0.9 after 80-100 h. For xanthine, the
median of the measured serum concentration< feil below
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Fig. 3a—b Serum hypoxanthine concentrations, serum xanthine
concentrations, total creatine kinase activity and creatine kinase-
MB activity determined at different times after pain onset for
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25th-percentile (Iower broken line), 50th-percentile (medium solid
line) and 75th-percentile (upper broken line). The discriminator val-
ues for a specificity of 0.90 are added (right-hand axis, continuous
straight line).
the discriminator value for a specificity of 0.9 after
100-l25 h. After 125h the median of the total cre-
atine kinase serum activity feil below the upper limit
of the reference ränge used for this method in our lab-
oratory.
Cpnclusions
This clinical study of purine rrietabolism, following
myocardial ischaemia fesulting frprn myocardial infarc-
tion, was perfbrmed in order to elucidate the possible
role of xanthine oxidoreductase iri tissüe alterations in
the post-ischaemic phäse. During ischaemia there is a
calcium-dependent enzymatic degradation of xanthine
oxidoreductase frorn the NAD+-consurning dehydroge-
nase form to an oxidase form, which directly utilizes
moleculär oxygen äs an electron acceptor in the oxida-
tion of hypoxanthine via xanthine to uric acid (1,4^5).
This enzyme could yield very reactive, oxygen-derived
radical ions, which could, if not scavenged by appropri-
ate radical-scavengers, lead to fiirther tissüe destruction
(6).
To assess the detectability of changes of purine metabo-
lism in myocardial tissüe, using peripheral serum sam-
ples, the results for serum hypoxanthine, xanthine, the
sum (hypoxanthine -K xanthine) and the ratio (xanthine/
hypoxanthine) were determined in blood samples of
n = 155 patients suffering from myocardial infarction
versus appropriate reference collectives. The data shown
in figure l a—b and summarized in table l indicate an
increased efflux of hypoxanthine and xanthine from the
injured tissüe similar to the efflux of creatine kinase.
The sensitivity and specificity data calculated from the
distributions of purine serum concentrations show that
the elevation of the serum xanthine concentration is
most specific for the patients with myocardial infarction.
The determination of hypoxanthine is much more unspe-
cific; this analyte is subject to preanalytical errors (7),
but cell death and damage might also be responsible for
an increase of the hypoxanthine serum concentration.
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The derived quantities, the sum (hypoxanthine + xan-
thine) and the ratio (xanthine/hypoxanthine) are less in-
formative about disease-specific metabolic changes, but
the unequivocal increase of serum xanthine must be due
to xanthine oxidoreductase activity directly connected
with the metabolic changes of myocardial ischaemia.
Consequently, the values for xanthine in the samples
drawn between approximately 5 hours and 6 days after
pain onset (from the patients kept ander surveillance af-
ter initial hospitalization in the cardiological intensive
care unit) show an elevation above a discriminator value
required for a specificity of 0.90 for the longest time
after pain onset.
The main result of this study is that the xanthine concen*
tration measured in serum derived from peripheral blood
is significantly increased in samples of patients suffering
from myocardial infarction, compared with sera of an
appropriate reference collective. The metabolic activity
of xanthine oxidoreductase in myocardial infarction has
therefore been proven in this study, and the fact that the
release of xanthine persists for four to five days after
pain onset on a level above the normal ränge, Supports
the role of xanthine oxidoreductase, which has been pre-
viously and controversially suggested (9—14).
On the other hand, the existence of oxygen-derived radi-
cals was not supported by examination of a radical-scav-
enging mechanism, the spontaneous oxidation of uric <<
acid to allantoin. Grootveld (8) has shown that allantoin '.;
is the best marker for the detection of oxygen-radical ;·
induced spontaneous oxidation of uric acid and therefore
the best index for the activity of uric acid äs a radical-
scavenger. Table 2 shows that there is no difference be-
tween the groups (see tab. 1) with respect to uric acid
or allantoin. But the absence of a response by allantoin
only hidicates that the oxygen^radicals, if generated, are
preferably subject to other radical-scavenging mecha-
nismSj in contrast to the diseases described by Groot-
veld (8).
Therefore, the clinical relevance of the findings in this ·
study depends on the validity of those resülts that indi- '"'
cate that the oxygen-consuming O-form of the xanthine
oxidoreductase is the predöminant form in the later
phase of myocardial infarction (15).
For elimination of the remaining ambiguities of the pre^
sent resülts, additional studies must be performed to
clarify qf the origin, the kinetics and the fate of the xan-
thine oxidoreductase involved in the metabolic changes
following myocardial infarction. Additionally, the origin
of the purine metabolites that lead tö the long-term ele-
vation of the xanthine effusion from the heart must be
elücidated.
References
1. MC Cord, J. M. (1987) Oxygen-derived radicals: A link be-
tween reperfusion injury and inflammation. Fed. Proc. 46,
2402-2406.
2. De Scheerder, I. K., van de Kraay, A. M. M., Lamers, J. M.
J., Koster, J. F, de Jong, J. W. & Serruys, P. W. (1991) Myocar-
dial malondialdehyde and uric acid release after short-lasting
coronary occlusions during coronary angioplasty: Potential
mechanisms for free radical generation. Am. J. Cardiol. 68,
392-395.
3. Kock, R., Delvoux, B. & Greiling, H. (1993) A high-perfor-
mance liquid Chromatographie method for the determination
of hypoxanthine, xanthine, uric acid and allantoin in serum.
Eur. J. Clin. Chem. Clin. Biochem. 31, 303-310.
4. Iriyama, K. (1987) Uric acid in ischemic tissue. Jikeikai Med.
J. 34, 145-168.
5. MC Cord, J. M. & Fridovich, L (1968) The reduction of cyto-
chrome c by milk xanthine oxidase. J. Biol. Chem. 243,
5753-5760.
6. MC Cord, J. M. (1985) Oxygen-derived free radicals in post-
ischemic tissue injury. N. Engl. J. Med. 312, 159-163.
7. Boulieu, R., Bory, C., Baltassat, P. & Gönnet, C. (1983) Hypo-
xanthine and xanthine levels determined by high-performance
liquid chromatography in plasma, erythrocyte, and urine sam-
ples from healthy subjects: The problem of hypoxanthine level
evolution äs a function of time. Anal. Biochem. 729,398-404.
8. Grootveld, M. & Halliwell, B. (1987) Measurement of allan-
toin and uric acid in human body fluids. Biochem. J. 243,
803-808.
9. Betz, A. L., Randall, J. & Martz, J. (1991) Xanthine oxidase
is not a major source of free radicals in focal cerebral
ischemia. Am. J. Physiol. 260 (Heart Circ. Physiol. 29«),
H563-H568.
10. Werns, S. W., Shea, J. J., Mitsos, S. E., Dysko, R. C., Fantpne,
J. C., Schork, M. A., Abrams, G. D., Pitt, B. & Lucchesi, B.
R. (1986) Reduction of the size of infarction by allopurinol in
the ischemicrieperrused canine heart. Cifculation 73, 518—
524.
11. Chambers, D. E., Parks, D. A., Paterson, G., Roy, R. S., MC
Cord, J. M., Yoshida, S., Parmleyj L. & Downey, J. M. (1985)
Xanthine oxidase äs a source of free radical in myoeardial
ischemia. J. Moll. Cell. Cardiol. 17, 145-152.
12. Hammond, B., Kontos, H. A. & Hess, M. L. (1985) Oxygen
radicals in the adult respiratory distress syndrome, in myocar-
dial ischemia and reperfusion injury, and in cerebral vascular
damage. Can. J. Physiol. Pharmaeol. 63, 173-187.
13. Peterson, D. A., Asinger, R. W., Elsperger, K. J., Homans^ D.
C. & Eaton, J. W. (1985) Reactive oxygen species may cause
myocardial reperfusion injury. Biochem. Biophys. Res. Comm.
727, 87-93.
14. Stoltenberg, L., Rootvelt, T., 0yasaeter, S., Rognum; T. O. &
Saugstad, O. A. (1993) Hypoxanthine, xanthine, and uric
acid concentrations in plasma, cerebrospinal fluid, vitreous
humor, and urine in piglets subjected to intermittent versus
cöntinuoüs hypoxemia. Pediatr. Res. 34, 767-77-1.
15. Becker, B. J. (1993) Towards the physiologieal function of uric
acid. Free Radical Biol. Med. 14, 615-631.
Dr. R. Kock






Eür. J. Clin. Chem. Clin. Bioehem. / Vol. 32,1994/No. 11 '!
